United States · FDA National Drug Code directory

SENSORCAINE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
63323-467_2b1a1f80-cb29-4ac1-9e72-20225ed45715
Product NDC
63323-467
Form
INJECTION, SOLUTION
Composition / generic term
BUPIVACAINE HYDROCHLORIDE
Labeler
Fresenius Kabi USA, LLC
Marketing category
NDA
Marketing start / end (source format)
20101119
Source listing expiry
20261231

Source-listed ingredients

  • BUPIVACAINE HYDROCHLORIDE — 5 mg/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 25 VIAL, MULTI-DOSE in 1 TRAY (63323-467-57) / 50 mL in 1 VIAL, MULTI-DOSE (63323-467-01) · 63323-467-57

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
SENSORCAINE — United States | Molindra Medicines